中文 | English
Return
Total: 111 , 1/12
Show Home Prev Next End page: GO
Author:(Xiaoguang ZHU)

1.Impact of Modified Bazhen Decoction on Bone Marrow Fibroblast Growth Factor-1 in Chronic Aplastic Anemia Patients

Lingling ZHU ; Xiaoguang ZHU

Journal of Guangzhou University of Traditional Chinese Medicine 2015;(5):830-833

2.The protective effects of TGP on local cerebral ischemia in rat

Huapu WU ; Xiaoguang ZHU

Chinese Pharmacological Bulletin 2001;17(2):223-225

3.miR-375 promotes prostate cancer cell migration and invasion by targeting KLF4

Enshan PAN ; Yugang LI ; Xiaoguang ZHU

Chongqing Medicine 2017;46(23):3184-3188

4.Inhibitory and apoptosis-inducing effects of aspisol on proliferation of B16 melanoma

Hailun ZHENG ; Yuelin ZHANG ; Xiaoguang ZHU

Chinese Pharmacological Bulletin 2003;0(10):-

5.Clinical effects of the open versus closed high tibial osteotomy on knee osteoarthritis

Xiaoguang ZHU ; Qingzhou PENG ; Dapeng WANG

Chinese Journal of Geriatrics 2021;40(4):491-495

6.Randomized Controlled Study on Warm-promotion Needling for Treatment of Cold Coagulation and Blood Stasis of Primary Dysmenorrhea

Runjie SUN ; Liang TIAN ; Bowen ZHU ; Xiaoguang QIN

Chinese Journal of Information on Traditional Chinese Medicine 2016;(1):23-26

7.Correlation study of cerebral white matter lesion with cognitive dysfunction after traumatic brain injury

Yongshan ZHU ; Yulong ZHANG ; Haiyun CHENG ; Xiaoguang LI ; Kunlin XIONG

Chinese Journal of Trauma 2016;32(1):69-73

8.Meta-analysis on Randomized Controlled Clinical Trials of Acupuncture and Moxibustion for Rheumatoid Arthritis

Xinghua ZHANG ; Bowen ZHU ; Binyuan ZHAO ; Xiaoguang QIN ; Xiaozheng DU

Chinese Journal of Information on Traditional Chinese Medicine 2015;(2):42-46

9.Design, synthesis and biological evaluation of novel para-substituted 1-benzyl-quinazoline-2, 4 (1H, 3H)-diones as human PARP-1 inhibitors.

Haiping YAO ; Zhixiang ZHU ; Ming JI ; Xiaoguang CHEN ; Bailing XU

Acta Pharmaceutica Sinica 2014;49(4):497-503

10.Synthesis and activity evaluation of PARP-1 inhibitors with azaindole skeleton.

Jie ZHOU ; Zhixiang ZHU ; Xiaoguang CHEN ; Bailing XU

Acta Pharmaceutica Sinica 2013;48(12):1792-9

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 111 , 1/12 Show Home Prev Next End page: GO